Clinical Trial Update: Remaxol® in Mechanical Jaundice of Non-malignant Origin [Phase 3]

View source ↗

Summary

Phase 3 trial update for Remaxol® in mechanical jaundice of non-malignant origin (obstructive jaundice) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Jaundice
• Obstructive Jaundice

Drugs mentioned

• Remaxol

Snippet

Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company | Conditions: Jaundice, Obstructive | Phase 3 | Status: COMPLETED